The Norris Cotton Cancer Center (NCCC) is a Comprehensive Cancer Center which has had support from the National Cancer Institute for the past 18 years. The NCCC is a component of the Dartmouth-Hitchcock Medical Center (DHMC) that has the overall responsibility for cancer research on this campus. The cancer research programs in the NCCC are facilitated by an administrative structure in which the Director, who is appointed as an Assoc. Vice President reports to the board of Trustees of the DHMC through the Senior Operations committee. Program development and planning in the NCCC are facilitated by: the Senior Leadership Group, which consists of a Deputy Director, Associate Director for Cancer Control, and the NCCC administrator; and an Executive Committee comprised of the Senior Leadership Group, the leaders of all the Research Programs, the chair of the Cancer Committee of the Mary Hitchcock Memorial Hospital, and the Directors of the Shared Resources. The NCCC supports Research Programs in Cancer Etiology, Cancer Prevention, Cell/Molecular Biology, Clinical Therapeutics, Developmental Therapeutics, Endocrinology, Immunology, and Radiation/Bioengineering. The goal of these programs is interactive, multi-disciplinary research which might have translational value. The NCCC provides shared resources for its investigators in biostatistics, clinical pharmacology, clinical research , editorial services, flow cytometry and fluorescence imaging, glassware washing,hybridoma library and monoclonal antibody production, irradiation, macromolecular core laboratory services, and tissue/sera procurement and histology.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA023108-17
Application #
2087125
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1978-09-01
Project End
1998-06-30
Budget Start
1994-09-01
Budget End
1995-08-31
Support Year
17
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Dartmouth College
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Barr, Fiona D; Ochsenbauer, Christina; Wira, Charles R et al. (2018) Neutrophil extracellular traps prevent HIV infection in the female genital tract. Mucosal Immunol 11:1420-1428
Jackson, Brian P (2018) Low level determination of gallium isotopes by ICP-QQQ. J Anal At Spectrom 33:897-900
Rahme, Gilbert J; Luikart, Bryan W; Cheng, Chao et al. (2018) A recombinant lentiviral PDGF-driven mouse model of proneural glioblastoma. Neuro Oncol 20:332-342
Wang, Zhaoxi; Wei, Yongyue; Zhang, Ruyang et al. (2018) Multi-Omics Analysis Reveals a HIF Network and Hub Gene EPAS1 Associated with Lung Adenocarcinoma. EBioMedicine 32:93-101
Sergent, P A; Plummer, S F; Pettus, J et al. (2018) Blocking the VISTA pathway enhances disease progression in (NZB?×?NZW) F1 female mice. Lupus 27:210-216
Kachuri, Linda; Saarela, Olli; Bojesen, Stig Egil et al. (2018) Mendelian Randomization and mediation analysis of leukocyte telomere length and risk of lung and head and neck cancers. Int J Epidemiol :
Rodriguez-Garcia, Marta; Fortier, Jared M; Barr, Fiona D et al. (2018) Aging impacts CD103+ CD8+ T cell presence and induction by dendritic cells in the genital tract. Aging Cell 17:e12733
Shajani-Yi, Zahra; de Abreu, Francine B; Peterson, Jason D et al. (2018) Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing. Neoplasia 20:256-262
Shee, Kevin; Jiang, Amanda; Varn, Frederick S et al. (2018) Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER+ breast cancer. FASEB J :fj201801241R
Bossé, Yohan; Amos, Christopher I (2018) A Decade of GWAS Results in Lung Cancer. Cancer Epidemiol Biomarkers Prev 27:363-379

Showing the most recent 10 out of 1911 publications